Dan Inbar

463 total citations
8 papers, 366 citations indexed

About

Dan Inbar is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Dan Inbar has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Dan Inbar's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Chemical Synthesis and Analysis (3 papers). Dan Inbar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Chemical Synthesis and Analysis (3 papers). Dan Inbar collaborates with scholars based in Israel and United States. Dan Inbar's co-authors include David Givol, Jacob Hochman, Miriam Rotman, Arthur H. Hale, Herman N. Eisen, Vivien Igras, Jacqueline Sharon, Izchak Z. Steinberg, Joseph Schlessinger and Israel Pecht and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Dan Inbar

8 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Inbar Israel 7 288 240 90 29 26 8 366
Jerry M. Anchin United States 11 355 1.2× 182 0.8× 77 0.9× 13 0.4× 29 1.1× 21 472
Eskil Söderlind Sweden 13 666 2.3× 524 2.2× 98 1.1× 7 0.2× 73 2.8× 19 759
Adeola O. Grillo United States 6 315 1.1× 145 0.6× 16 0.2× 26 0.9× 39 1.5× 7 363
Barrie C. Rooney United Kingdom 7 235 0.8× 67 0.3× 54 0.6× 14 0.5× 11 0.4× 14 323
D. Y. JACKSON United States 5 263 0.9× 123 0.5× 65 0.7× 9 0.3× 10 0.4× 5 349
Shojiro Kadono United States 9 191 0.7× 180 0.8× 97 1.1× 40 1.4× 51 2.0× 18 317
Susan Chacko United States 10 237 0.8× 87 0.4× 48 0.5× 8 0.3× 40 1.5× 12 339
Theresa Martinez United States 9 417 1.4× 365 1.5× 89 1.0× 29 1.0× 13 0.5× 11 525
Anne‐Marie Duplaa France 10 372 1.3× 34 0.1× 119 1.3× 57 2.0× 10 0.4× 14 514
Mariangela Spitali United Kingdom 4 212 0.7× 145 0.6× 38 0.4× 9 0.3× 10 0.4× 10 331

Countries citing papers authored by Dan Inbar

Since Specialization
Citations

This map shows the geographic impact of Dan Inbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Inbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Inbar more than expected).

Fields of papers citing papers by Dan Inbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Inbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Inbar. The network helps show where Dan Inbar may publish in the future.

Co-authorship network of co-authors of Dan Inbar

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Inbar. A scholar is included among the top collaborators of Dan Inbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Inbar. Dan Inbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Inbar, Dan, Arthur H. Hale, Vivien Igras, & Herman N. Eisen. (1979). Soluble trinitrophenylated proteins and trinitrophenylated cells as specific inhibitors of target cell lysis by cytotoxic T lymphocytes. Cellular Immunology. 42(2). 298–307. 6 indexed citations
2.
Hale, Arthur H., et al.. (1978). Loss of reactivity of a BALB/c myeloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes. European Journal of Immunology. 8(9). 640–645. 13 indexed citations
3.
Givol, David, Jacqueline Sharon, Jacob Hochman, et al.. (1977). Folding, Association, and Interactions of Domains in the Antibody Molecule. Cold Spring Harbor Symposia on Quantitative Biology. 41(0). 667–675. 7 indexed citations
4.
Hochman, Jacob, et al.. (1976). Folding and interaction of subunits at the antibody combining site. Biochemistry. 15(12). 2706–2710. 41 indexed citations
5.
Hochman, Jacob, Dan Inbar, & David Givol. (1973). Active antibody fragment (Fv) composed of the variable portions of heavy and light chains. Biochemistry. 12(6). 1130–1135. 120 indexed citations
6.
Inbar, Dan, David Givol, & Jacob Hochman. (1973). Circular dichroism study of the antibody combining site. Biochemistry. 12(22). 4541–4543. 13 indexed citations
7.
Inbar, Dan, Jacob Hochman, & David Givol. (1972). Localization of Antibody-Combining Sites within the Variable Portions of Heavy and Light Chains. Proceedings of the National Academy of Sciences. 69(9). 2659–2662. 109 indexed citations
8.
Inbar, Dan, Miriam Rotman, & David Givol. (1971). Crystallization with Hapten of the Fab' Fragment from a Mouse IgA Myeloma Protein with Antidinitrophenyl Activity. Journal of Biological Chemistry. 246(20). 6272–6275. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026